Are Psychedelics on the Verge of Going Mainstream?

From Solutions with Henry Blodget by Vox Media Podcast Network

May 11, 2026 · 40 min

About this episode

The episode discusses the potential mainstream acceptance of psychedelics following recent political support and their therapeutic benefits.

President Trump surprised many people a few weeks ago when he signed an executive order accelerating research into psychedelics. Compounds like psilocybin, LSD, MDMA, ketamine, and others have developed large and enthusiastic followings in the past decade, and some seem quite promising in the treatment of depression, PTSD, addiction and other conditions. Unusually, they are also one of the very few issues that have support across the political spectrum. This week, we discuss why this is a turning point for psychedelics and what might come next with Anne Philippi, a former journalist at Vogue, Vanity Fair, and GQ who now runs The New Health Club, a media organization dedicated to psychedelics. Learn more about your ad choices. Visit podcastchoices.com/adchoices

People in this episode

Host: Henry Blodget

Guest: Anne Philippi

Topics covered

psychedelics
mental health
politics
treatment
research
depression
PTSD

Keywords

psychedelics
mental health
treatment
depression
PTSD
research
executive order
political support

Mentioned in this episode

Organizations: The New Health Club, Vogue, Vanity Fair, GQ

Products: psilocybin, LSD, MDMA, ketamine